论文部分内容阅读
本文25例不典型再生障碍性贫血,按其骨髓增生及血细胞减少情况分为:一、骨髓增生减低组15例。二、骨髓增生活跃、明显活跃组7例。以上两组,单纯一组血细胞减少5例,两组血细胞减少17例。三、全血细胞减少伴骨髓涂片增生活跃,但活检增生减低组3例。第二、三组病例应与增生型再障及难治性贫血鉴别。我们认为重视不典型再障的诊断,目的在于早期诊断防止漏诊误诊,以便及时治疗,有利于骨髓造血功能恢复。
25 cases of atypical aplastic anemia, according to their myeloproliferation and cytopenia are divided into: First, the myeloproliferative reduction group of 15 cases. Second, bone marrow hyperplasia, obviously active group of 7 cases. More than two groups, a simple group of cytopenias in 5 cases, two cases of cytopenia in 17 cases. Third, pancytopenia with bone marrow smear hyperplasia, but biopsy reduced group of 3 cases. The second and third groups of cases should be distinguished from proliferative aplastic anemia and refractory anemia. We believe that attention to diagnosis of atypical aplastic anemia, the purpose is to prevent early diagnosis of missed misdiagnosis in order to timely treatment, is conducive to bone marrow hematopoietic recovery.